EEOC Prohibits Employers from Requiring Employees to Have SARS-CoV-2 Antibody Testing to Return to Work
![return to work covid-19 testing policy developing](https://covid19briefings.com/wp-content/uploads/2020/07/AS_88210686-covid-19-testing-return-to-work-policy-sm-1024x703.jpg)
What the US Equal Employment Opportunity Commission (EEOC) updated in its June 17 guidance to employers on COVID-19 testing.
Federal Agencies Answer Frequently Asked Questions About Implementation of Health Coverage Issues Related to COVID-19
![insurance coverage issues with covid-19 testing](https://covid19briefings.com/wp-content/uploads/2020/07/AS_88210686-covid-19-testing-insurance-questions-1024x703.jpg)
Five points of interest to clinical laboratory leaders, gleaned from an over 8,000-word payer guidance document jointly developed by federal agencies.
Antigen SARS-CoV-2 Diagnostic Test EUA Update
![FDA-building-sign](https://covid19briefings.com/wp-content/uploads/2020/05/FDA-building-sign-1024x576.jpg)
This point-of-care test can potentially scale up to test millions, according to FDA Commissioner Stephen Hahn, MD.
Nationwide Push for Convalescent Plasma Expected to Increase the Need for SARS-CoV-2 Serology and Specialized Medical Laboratory Testing
![convalescent plasma therapy as a COVID-19 treatment](https://covid19briefings.com/wp-content/uploads/2020/07/AdobeStock-238898515-plasma-convalescent-therapy-1024x756.jpg)
An interview with Mayo Clinic’s Elitza Theel, PhD, presents an overview of the state of convalescent plasma treatment for COVID-19.